Non-invasive diagnosis of portal hypertension in cirrhosis. Application to the primary prevention of varices

被引:23
作者
Dib, N [1 ]
Konate, A [1 ]
Oberti, F [1 ]
Cales, P [1 ]
机构
[1] CHU Angers, Serv Hepatogastroenterol, Lab HIFIH, UPRES,EA 3859,IFR 132, F-49933 Angers, France
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2005年 / 29卷 / 10期
关键词
D O I
10.1016/S0399-8320(05)88170-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
One of the major complications of cirrhosis is the occurrrence of portal hypertension and esophageal varices. At present, universal endoscopic screening of esophageal varices is recommended in association to primary prophylaxis in patients at high risk of variceal bleeding. But this screening is invasive and could be not cost-effective. Besides, pre-primary phrophylaxis is not effective and hampared by side effects. So, non invasive diagnosis of portal hypertension might be useful. This one could depend on non invasive measurement of hepatic venous pressure gradient, but its application to screening is not well-documented and its use in treatment monitoring is debated. A second way could be non invasive diagnosis of large esophageal varices because of prognostic and economic issues. Indirect echographic markers of portal hypertension and esophageal varices (ascites, portal vein diameter ? 13 mm, spleen length, maximal and mean velocimetry of portal vein flow, respectively < 20 cm/s and < 12 cm/s) could be useful. Among this parameters, spleen length is an independent predictive marker of esophageal varices. Besides, several direct or indirect blood markers of fibrosis have been tested. Platelet count is repeatedly a predictive marker of esophageal varices in multivariate analysis. The other predictive factors of esophageal varices could be: prothrombin time, splenomegaly, spider naevi, Child-Pugh class, bilirubinemia, platelet count/spleen diameter ratio and Fibrotest, but these data require validation. In summary, in regard to actual results, non invasive diagnosis of portal hypertension might be useful in esophageal varices screening, but the substitutes to endoscopy have limited place actually in clinical practice, and exclusive non invasive diagnosis of portal hypertension is not applicable; the only test that seems to be useful in clinical practice is conventional endoscopy awaiting the results of videocapsule.
引用
收藏
页码:975 / 987
页数:13
相关论文
共 123 条
[11]   A la carte or menu fixe: Improving pharmacologic therapy of portal hypertension [J].
Bosch, J .
HEPATOLOGY, 2002, 36 (06) :1330-1332
[12]   NONINVASIVE MEASUREMENT OF THE PRESSURE OF ESOPHAGEAL-VARICES USING AN ENDOSCOPIC GAUGE - COMPARISON WITH MEASUREMENTS BY VARICEAL PUNCTURE IN PATIENTS UNDERGOING ENDOSCOPIC SCLEROTHERAPY [J].
BOSCH, J ;
BORDAS, JM ;
RIGAU, J ;
VIOLA, C ;
MASTAI, R ;
KRAVETZ, D ;
NAVASA, M ;
RODES, J .
HEPATOLOGY, 1986, 6 (04) :667-672
[13]  
BOSCH J, 1984, HEPATOLOGY, V4, P355
[14]   Changing clinical practice with measurements of portal pressure [J].
Boyer, TD .
HEPATOLOGY, 2004, 39 (02) :283-285
[15]  
BOYER TD, 1977, GASTROENTEROLOGY, V72, P584
[16]  
BRAILLON A, 1984, GASTROEN CLIN BIOL, V8, P47
[17]   INFLUENCE OF THE DEGREE OF LIVER-FAILURE ON SYSTEMIC AND SPLANCHNIC HEMODYNAMICS AND ON RESPONSE TO PROPRANOLOL IN PATIENTS WITH CIRRHOSIS [J].
BRAILLON, A ;
CALES, P ;
VALLA, D ;
GAUDY, D ;
GEOFFROY, P ;
LEBREC, D .
GUT, 1986, 27 (10) :1204-1209
[18]   A la carte treatment of portal hypertension:: Adapting medical therapy to hemodynamic response for the prevention of bleeding [J].
Bureau, C ;
Péron, JM ;
Alric, L ;
Morales, J ;
Sanchez, J ;
Barange, K ;
Payen, JL ;
Vinel, JP .
HEPATOLOGY, 2002, 36 (06) :1361-1366
[19]   Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? [J].
Burroughs, AK ;
Groszmann, R ;
Bosch, J ;
Grace, N ;
Garcia-Tsao, G ;
Patch, D ;
Garcia-Pagan, JC ;
Dagher, L .
GUT, 2002, 50 (03) :425-427
[20]  
*C CONS, 2004, GASTROENTEROL CLIN B, V28, pB324